Pfizer, Lilly drugs slow advanced breast cancer in studies
Pfizer Inc., Eli Lilly and Co. and Novartis AG have dug an idea out of the pharmaceutical dustbin to create new medicines that are showing blockbuster potential.
Health Care & Life Sciences
Articles
Hospitals might chip in to expand Medicaid
If Indiana hospitals want an expansion of insurance coverage for low-income Hoosiers, Gov. Mike Pence thinks they should contribute toward the hundreds of millions of dollars it would cost.
IU Health doctors to do surgeries in Wisconsin
Indiana University Health was chosen by a hospital system in Wisconsin to provide heart, lung, esophagus and aorta surgeries there after the surgeons the hospital system had been using became employed by a competing provider.
The Millionaire Doctors Club
The scramble for physicians by hospitals in recent years has led to more than a dozen physicians cracking a million dollars in compensation—and three dozen receiving at least a half million dollars. Hospitals, meanwhile, are recording big losses on their physician practices.
UPDATE: Nine at dental practice charged in fraud probe
Prosecutors have charged the owner of an Anderson dental practice and eight of her employees in connection with a Medicaid fraud investigation.
Big health care insurers bulk up executive pay
WellPoint CEO Joe Swedish wasn’t the only health insurance exec making big bucks last year. Aetna Inc. Chairman and CEO Mark T. Bertolini saw his total compensation more than double, to top $30 million.
CarDon trying to adjust nursing homes to hospitals, insurers, patients
Family-run company is building nursing homes it thinks will be more attractive to residents and staff.
Patent ‘troll’ label gets Congress to ponder what’s in a name
“Troll” is a term without clear definition and yet it’s being used to push Congress and the Supreme Court to curb abusive litigation. Companies including Eli Lilly warn against damaging a centuries-old system designed to promote advances in science and industry.
Would-be Lilly foe wins U.S. panel backing for inhaled insulin
Advisers to the Food and Drug Administration voted 13-1 and 14-0 that the drug, Afrezza, should be approved for Type 1 and Type 2 diabetes, respectively. The FDA doesn’t have to follow the panel’s recommendation.
Indianapolis court backs patent for Lilly cancer drug Alimta
A federal court has upheld the patent that protects Eli Lilly and Co.'s lung-cancer treatment from generic competition until 2022.
Pence continues to seek repeal of medical device tax
A number of Indiana lawmakers – including both of the state’s U.S. senators – have advocated for the elimination of the tax, in part because the state is home to several key medical device manufacturers.
Obamacare sign-ups on track to hit 7 million, sources say
The 7 million target, thought to be out of reach by most experts, was in sight on a day that saw surging consumer interest as well as vexing computer glitches.
Deadline brings crush of Indiana health coverage applicants
The last-minute flood of applicants in Indiana mirrored national trends as people sought to at least start the process Monday.
Do double-digit Obamacare rate hikes mean the law has failed? No, but …
For now, at least, the year-to-year price increases of individual insurance under Obamacare look a lot like they did before Obamacare. That’s not a failure, but it’s not a success either.
IU Health suffers small decline in 2013 profit
Indiana University Health’s business deteriorated last year in nearly every area. But price hikes and a surge in outpatient visits to Indianapolis-area facilities mostly offset those problems.
Cancer treatment makes Endocyte premium takeover target
Now that Indiana-based Endocyte Inc.’s experimental cancer treatment is proving successful, the company may command a takeover bid at one of the industry’s highest premiums on record.
Would-be Lilly competitor’s inhaled insulin tied to lung concerns
Afrezza, a powdered insulin used through an inhaler, would be the MannKind Corp.’s first marketed product. The treatment would compete against Lilly’s Humalog. An FDA report tied the drug to a decline in lung function.
Obama says more than 6M signed up for health care
Like much else about Obama's health care law, the milestone comes with a caveat: The administration has yet to announce how many consumers actually closed the deal by paying their first month's premium.
Where do hospital profits go?
When patients at Indianapolis-area hospitals pay their bills, they're not just funding their own health care. They're contributing to the care of Hoosiers in the rest of the state, too, especially care provided by hospital-employed physicians.